Medicube is facing serious legal heat in 2026. The Korean beauty giant is under fire from consumers, regulators, and legal advocates across three separate fronts: a banned toxic dye found in one of its bestselling creams, injury claims tied to its viral AGE-R Booster Pro device, and a government-enforced advertising suspension for making misleading product claims.
If you bought a Medicube product this year, you may have legal options.
This article breaks down every active legal issue involving Medicube. You’ll learn what happened, which products are affected, who can file a claim, and what any potential settlement could look like.
One fact stands out immediately: consumers who used the Medicube PDRN Pink Collagen Capsule Cream need to know about the ongoing scandal involving a toxic and potentially carcinogenic substance detected by the Hong Kong Government Laboratory, a controversy that began in late July 2026.
Medicube Lawsuit: The Full 2026 Story
The Medicube lawsuit situation in 2026 is not a single case. It is a web of overlapping consumer complaints, regulatory sanctions, and injury allegations.
Three distinct legal issues are driving the conversation right now. Each involves different products. Each affects different groups of consumers.
Understanding all three is key to knowing where you stand legally.
| Issue | Product Involved | Legal Category |
|---|---|---|
| Sudan Red contamination | PDRN Pink Collagen Capsule Cream | Product safety / consumer protection |
| Device injuries (Bell’s Palsy) | AGE-R Booster Pro | Product liability / personal injury |
| Misleading medical claims | Exosome Pore Ampoules | False advertising / regulatory violation |
No court-certified U.S. class action has been formally filed as of September 2026. But the volume of consumer complaints, FDA adverse event reports, and international regulatory actions is building the foundation for one.
Medicube Class Action 2026: Where Things Stand
A formal Medicube class action lawsuit in 2026 has not been certified by a U.S. federal court yet. That is the honest answer.
What does exist is significant. The FDA’s MAUDE adverse event database contains updated reports as of July 31, 2026 tied to the Medicube AGE-R Booster Pro device. BBB complaint volumes have grown. And international regulators have already taken action against the brand.
Class actions typically begin this way. Consumer complaints pile up. Attorneys monitor regulatory findings. A lead plaintiff steps forward.
| Class Action Stage | Current Status (Sept 2026) |
|---|---|
| Consumer complaints filed | Active, multiple platforms |
| FDA adverse event reports | Confirmed filings on record |
| Regulatory sanctions (global) | Confirmed in South Korea and Hong Kong |
| U.S. class action certified | Not yet confirmed |
| Settlement negotiations | Not yet public |
The conditions for a class action are forming. If you were harmed by a Medicube product, documenting your experience now matters.
Why Is Medicube Being Sued?
Medicube is being sued, and faces regulatory sanctions, because of three documented problems with its products and marketing.
First, Hong Kong authorities detected a banned industrial dye in a Medicube cream. Second, consumers report serious injuries from its electrical device. Third, South Korean regulators found its advertising crossed the legal line between cosmetics and medicine.
Any one of these issues could anchor a lawsuit. All three together point to a pattern.
- Banned toxic ingredient detected by a government laboratory
- Multiple consumer reports of skin burns, nerve injuries, and facial damage
- Government-ordered advertising suspension for making drug-like claims
Regulators found that Medicube used expressions in their advertisements that could mislead consumers into believing the cosmetics were pharmaceutical products, and this action is part of a broader crackdown by the Korean Ministry of Food and Drug Safety on exaggerated “medical-lite” claims.
That is a significant finding. It means Medicube’s own government agrees the marketing misled buyers.
Key Takeaway: Medicube faces legal exposure on three fronts simultaneously: ingredient safety, device injury, and false advertising, each affecting different consumers and products.
Medicube AGE-R Booster Pro Lawsuit
The Medicube AGE-R Booster Pro lawsuit claims center on serious physical injuries caused by the device’s electrical stimulation technology.
At least two users of the device have taken to social media to claim that the electrical stimulation triggered Bell’s Palsy. One of these users reported drooping in her eyelid, dilation of her pupil and impaired vision. The other had facial paralysis on one side, significantly affecting the position of her lip and her speech.
These are not minor side effects. These are debilitating, potentially permanent conditions.
The company was quick to respond with a statement saying that the intensity of the device was insufficient to cause harm to the nerve, and clinical trials backed up that claim. They added language to their product listing categorically denying that the device was the cause of the reported nerve injuries.
Medicube denies responsibility. But denial is not the same as proof.
| Reported Injury | Device | Legal Theory |
|---|---|---|
| Bell’s Palsy (facial paralysis) | AGE-R Booster Pro | Product liability |
| Eyelid drooping, impaired vision | AGE-R Booster Pro | Defective product / failure to warn |
| Skin burns and staining | AGE-R Booster Pro + serums | Product liability / negligence |
One consumer filed a formal complaint against Medicube regarding a product purchased through their TikTok store on March 21, 2025, and upon using one of the products, discovered it contained tiny shards of glass that caused multiple cuts on her face. That complaint alone raises serious product safety questions.
Medicube Sudan Red Banned Ingredient
Sudan Red is not just a controversial ingredient. It is a banned industrial dye that has no business being in a face cream.
The Medicube Sudan Red controversy began in late July 2026 after Hong Kong Customs reported that its Government Laboratory detected Sudan Red, a prohibited ingredient, in a Medicube PDRN Pink Collagen Capsule Cream bought from the local market. Hong Kong Customs advised consumers to stop using that cream and advised retailers to remove it from shelves.
Sudan Red is classified as a potential carcinogen. It is prohibited in cosmetics across most international markets.
Medicube released an official statement disputing the government agency’s findings, stating that tests conducted by an accredited Korean testing laboratory detected no traces of Sudan Red. However, Hong Kong Customs reported that testing confirmed the presence of Sudan Red in the sampled collagen cream.
Two government-level tests. Opposite results. That conflict is exactly the kind of factual dispute that drives litigation.
| Party | Finding | Sudan Red Detected? |
|---|---|---|
| Hong Kong Government Laboratory | Official government test | Yes |
| Medicube’s Korean laboratory | Brand-commissioned test | No (below detection limit) |
| Consumers | Adverse reactions reported | Ongoing |
A result of “not detected” does not necessarily mean zero presence of a substance. Depending on the laboratory and test used, it usually means that the substance was below the detection or reporting limit of the method used.
That distinction matters enormously in any product liability case.
Medicube False Advertising Lawsuit
Medicube’s false advertising problems are now a matter of regulatory record, not just consumer suspicion.
Medicube was ordered by South Korean regulators to suspend advertising for certain products in early 2026 due to violations of the Cosmetics Act. The ads for “One Day Exosome Pore Ampoule 2000” and “One Day Exosome Shot Pore Ampoule 7500” were ordered to be suspended until June 8, 2026. Regulators found that Medicube used expressions that could mislead consumers into believing the cosmetics were pharmaceutical products.
Think of it like a supplement company claiming their pill cures cancer. That is illegal. The same rule applies to skincare.
According to South Korea’s Ministry of Food and Drug Safety, cosmetics cannot make medical, therapeutic, or drug-like claims. The advertising suspension does not mean the products are unsafe; it just requires Medicube to adjust their marketing to follow cosmetic regulations.
In the United States, the FTC and FDA enforce similar rules. A regulatory finding abroad can and does inform U.S. consumer fraud litigation.
Key Takeaway: Medicube’s advertising suspension is not just a Korean issue. It validates what U.S. consumers suspected: the brand made claims it could not legally support.
Medicube Advertising Suspension Korea 2026
The Korean advertising suspension against Medicube is one of the most concrete regulatory actions the brand has faced to date.
Medicube was ordered by South Korean regulators to suspend advertising for certain products in early 2026 due to violations of the Cosmetics Act. The ads for “One Day Exosome Pore Ampoule 2000” and “One Day Exosome Shot Pore Ampoule 7500” were ordered suspended until June 8, 2026.
South Korea’s MFDS is not a minor agency. It is the regulatory equivalent of the U.S. FDA for cosmetics and food safety in Korea.
Medicube accepted the administrative action and pledged to provide more accurate information to consumers. That acceptance is legally meaningful. It signals the brand did not contest the findings.
| Enforcement Detail | Information |
|---|---|
| Enforcing Agency | Korean Ministry of Food and Drug Safety (MFDS) |
| Violation Type | Cosmetics Act: drug-like advertising claims |
| Products Affected | Exosome Pore Ampoule 2000; Exosome Shot Pore Ampoule 7500 |
| Suspension Period | Until June 8, 2026 |
| Brand Response | Accepted the administrative action |
This incident is part of increasing scrutiny on K-Beauty brands using aggressive marketing techniques around high-functionality ingredients. Medicube was not alone, but it was named specifically.
Medicube Bell’s Palsy Claims
Bell’s Palsy claims tied to the Medicube AGE-R Booster Pro are among the most serious allegations the brand faces.
Bell’s Palsy results from inflammation of the nerve that controls facial muscles, which is often, but not necessarily always, caused by a viral infection. When a device is introduced as a potential trigger, the causation question becomes the center of any legal case.
Some Medicube booster users claim the device caused nerve inflammation leading to Bell’s Palsy, and the manufacturer insists otherwise. The publicly available information is not sufficient to draw a final conclusion about whether the device may or may not have caused the reported incidents.
That uncertainty is exactly what makes legal action viable. Courts decide causation questions. Manufacturers do not get to do it unilaterally.
- Facial paralysis on one side of the face
- Eyelid drooping and pupil dilation
- Impaired speech and facial muscle control
- Impaired vision reported in at least one case
This raises the important question of how law protects consumers from dangerous or defective products. Relevant product liability statutes make a seller responsible for injuries caused by a defective product that is unreasonably dangerous to the user or consumer.
The standard is not “did the company intend harm.” It is whether the product was unreasonably dangerous.
Medicube PDRN Pink Collagen Cream Recall
No formal product recall has been issued by the FDA in the United States for the Medicube PDRN Pink Collagen Capsule Cream as of September 2026.
But the situation across international markets tells a more urgent story.
Hong Kong Customs issued a public consumer warning regarding the collagen face cream found to contain Sudan Red, an industrial dye strictly prohibited in cosmetic formulations. Authorities urged consumers to immediately stop using the product and instructed retailers to remove affected stock from shelves.
That is the functional equivalent of a recall, just without the U.S. formal recall label.
The alert follows a major safety scare in Taiwan in late November 2025, when illegal Sudan Red contamination spread from food products into skincare and color cosmetics, impacting over a hundred beauty SKUs across multiple well-known brands.
Medicube was caught up in a contamination wave that affected the broader region.
| Action | Authority | Date |
|---|---|---|
| Consumer warning issued | Hong Kong Customs | July 2026 |
| Retail removal advised | Hong Kong Customs | July 2026 |
| Medicube disputes findings | Brand statement | July 25, 2026 |
| FDA U.S. recall | Not issued as of Sept 2026 | Pending |
If you have this product, stop using it until testing results are independently confirmed.
Key Takeaway: The PDRN Pink Collagen Cream has been flagged by government authorities in Hong Kong for containing a banned carcinogenic dye, and retailers were told to pull it from shelves, even as Medicube disputes those findings.
Who Qualifies for Medicube Lawsuit
You may qualify for a Medicube legal claim if you purchased one of the flagged products and suffered a specific type of harm.
There are three general categories of qualifying consumers right now.
Category 1: AGE-R Booster Pro device users who suffered physical injury.
This includes nerve damage, facial paralysis, skin burns, electrical injury, or any documented adverse physical reaction from using the device.
Category 2: PDRN Pink Collagen Capsule Cream users.
If you used this product, especially after July 2026, and experienced adverse skin reactions, you may have standing based on the Sudan Red contamination findings.
Category 3: Consumers misled by false advertising.
If you purchased any Medicube product based on claims that it could “regenerate skin,” “improve pores medically,” or perform pharmaceutical-level functions, you may have a consumer fraud or false advertising claim.
| Who May Qualify | Product Used | Type of Harm |
|---|---|---|
| AGE-R Booster Pro users | AGE-R Booster Pro device | Physical injury, nerve damage, burns |
| PDRN Cream users | Pink Collagen Capsule Cream | Adverse skin reaction, toxic exposure |
| Deceived buyers | Exosome Ampoule products | Financial loss from misleading claims |
| Glass injury victims | Any TikTok Store Medicube product | Physical cuts, skin injury |
Proof of purchase and medical documentation of your injury will significantly strengthen any claim.
Medicube Product Liability Claim
A product liability claim against Medicube can be based on one of three legal theories, and you do not need to be a lawyer to understand them.
The first is manufacturing defect. This means the product was physically flawed when it left the factory. The glass contamination complaints and the Sudan Red contamination fall into this category.
The second is design defect. This means even when made correctly, the product is unreasonably dangerous. The Bell’s Palsy claims against the AGE-R Booster Pro fit this theory.
The third is failure to warn. This means Medicube did not adequately disclose known risks. Electric stimulation devices that carry nerve injury risk should carry clear, prominent warnings.
Relevant product liability statutes make a seller responsible for injuries caused by a defective product that is unreasonably dangerous to the user, consumer, or their property.
| Legal Theory | What It Means | Medicube Example |
|---|---|---|
| Manufacturing Defect | Specific unit was made wrong | Glass fragments in product; Sudan Red contamination |
| Design Defect | Product design is inherently dangerous | AGE-R Booster Pro nerve stimulation risk |
| Failure to Warn | Did not disclose known risks | No adequate warning about Bell’s Palsy risk |
You do not need to prove all three. One is enough to pursue a claim.
Medicube Injury Claim
Filing a Medicube injury claim starts with documenting your experience as thoroughly as possible.
Before anything else, preserve every piece of evidence you have. This is the single most important step you can take right now.
What to collect and preserve:
- Proof of purchase (receipts, order confirmation emails, bank statements)
- Photos of the product, packaging, and any injury or skin reaction
- Medical records, doctor visits, or emergency room reports related to your injury
- Any communication with Medicube’s customer service
- Screenshots of the product listing, including the claims made at time of purchase
- Any adverse reaction timeline you can write down from memory
When one consumer reported finding glass in a Medicube product, the company responded 48 hours later with a generic reply, failing to acknowledge the safety concern or take accountability.
That kind of corporate non-response is itself a documented pattern. It is relevant in litigation.
| Evidence Type | Why It Matters |
|---|---|
| Purchase receipt | Proves you are an eligible consumer |
| Photos of injury | Establishes physical harm |
| Medical records | Quantifies damages |
| Customer service records | Documents brand’s response (or lack of) |
| Product screenshots | Captures false advertising claims |
Time matters. Statutes of limitations vary by state, typically two to four years from the date of injury.
Key Takeaway: Documenting your purchase, injury, and any contact with Medicube is the single most important thing you can do right now to protect your legal rights.
Medicube Consumer Complaint
Consumer complaints against Medicube have been filed across multiple official channels in 2026.
The Better Business Bureau has logged numerous complaints involving the AGE-R Booster Pro device and various skincare products. At least one consumer contacted the business numerous times trying to get them to replace a damaged skincare device, and the company refused, leading the consumer to threaten civil product liability action for device-caused damage.
Filing a consumer complaint does more than vent frustration. It creates an official paper trail that attorneys and regulators can access when investigating a pattern of harm.
Where to file a Medicube consumer complaint:
- Better Business Bureau (bbb.org): For general consumer disputes and refund issues
- U.S. FDA MedWatch: For adverse reactions to the AGE-R Booster Pro device
- Federal Trade Commission (FTC): For false advertising and consumer deception
- Your state Attorney General’s consumer protection office: For state-level consumer fraud
One consumer noted they were prepared to see a civil lawsuit through no matter how long it takes if the company refused to resolve the issue. That determination is increasingly common among Medicube buyers.
Filing your complaint officially also makes you easier to find if a class action attorney begins organizing a case.
Medicube Lawsuit Settlement
No Medicube lawsuit settlement has been publicly announced in the United States as of September 2026.
That is not unusual. Most product liability settlements take one to three years from the first major complaint wave to reach resolution.
Think of it like a train leaving the station. The complaints are the fuel. The regulatory actions are the track. The settlement is the destination. Medicube’s train is moving, just not arrived yet.
What a potential settlement could include:
- Refunds for product purchases
- Medical cost reimbursement for documented injuries
- Additional compensation for pain, suffering, or permanent injury
- Injunctive relief requiring Medicube to change its advertising
| Settlement Type | Who It Typically Covers | Estimated Timeline |
|---|---|---|
| Consumer class action settlement | All buyers of flagged products | 2027 or later |
| Individual personal injury | Severe injury cases (Bell’s Palsy, nerve damage) | Varies by case |
| Refund-only resolution | Minor adverse reactions, financial harm only | Potentially sooner |
Consumers with serious physical injuries typically receive significantly more than those with only financial claims. The more documented your injury, the stronger your position.
Medicube Lawsuit Payout 2026
No official Medicube lawsuit payout amounts have been set or court-approved as of September 2026.
Estimating payouts requires understanding the range of harm types involved. Not all claims are equal.
Minor claims, like buying a product based on exaggerated advertising with no physical injury, tend to resolve at lower amounts in class settlements. Serious physical injury claims, particularly permanent nerve damage or facial paralysis, carry significantly higher individual damages.
| Harm Type | Potential Payout Range (Estimated) | Notes |
|---|---|---|
| Consumer fraud / misleading ads only | $25 to $200 | Typical small consumer class recovery |
| Adverse skin reaction, documented | $100 to $1,000 | Requires medical records |
| Burns, scarring, or moderate injury | $1,000 to $10,000+ | Requires photos and medical documentation |
| Bell’s Palsy or permanent nerve damage | $50,000 to $500,000+ | Individual litigation, not class action |
These are estimates based on comparable product liability and consumer class action cases. Actual amounts depend on the specific claims filed, the evidence presented, and whether a settlement or verdict is reached.
The stronger your documentation, the better your potential outcome.
Key Takeaway: Serious physical injury claims tied to the Medicube AGE-R Booster Pro carry far greater payout potential than financial-only consumer fraud claims, making medical documentation the most critical asset a claimant can have.
How to File a Medicube Lawsuit Claim
Filing a Medicube lawsuit claim in 2026 is a process, not a single step. Here is a clear path forward.
Step 1: Gather all your evidence. Purchase records, photos, medical documents, communications with the company. All of it.
Step 2: Report the incident officially. File with the BBB, the FDA’s MedWatch system if your injury involved the AGE-R device, and the FTC if you feel misled by advertising.
Step 3: Consult a product liability attorney. Most work on contingency, meaning you pay nothing unless they win. Product liability attorneys who handle K-beauty or consumer goods cases are your best starting point.
Step 4: Monitor class action development. If a formal class action is filed against Medicube in U.S. courts, class members are typically notified. Staying informed means you do not miss a deadline.
Step 5: File before your state’s statute of limitations expires. Most states allow two to four years from the date of injury. The clock is already running.
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Gather all evidence | Strengthens your claim |
| 2 | File official complaints | Creates public record |
| 3 | Contact a product liability attorney | Protects your rights legally |
| 4 | Track class action news | Ensures you do not miss opt-in deadlines |
| 5 | Act before your state’s deadline | Prevents claim from expiring |
This incident is part of increasing scrutiny on K-Beauty brands using aggressive marketing techniques around high-functionality ingredients, which means more regulatory and legal pressure on Medicube is likely coming.
Acting now puts you ahead of the filing curve.
Frequently Asked Questions
Is there a class action lawsuit against Medicube in 2026?
No formally certified U.S. class action against Medicube has been announced as of September 2026.
The legal groundwork is building, including FDA adverse event filings, BBB complaints, and international regulatory sanctions.
Consumers should document their experiences now and monitor class action developments closely.
What is the Sudan Red contamination found in Medicube products?
According to Hong Kong Customs, the Medicube PDRN Pink Collagen Cream was bought from the local market and sent to the Government Laboratory, which detected Sudan Red in the cream, a substance prohibited for use in cosmetics in Hong Kong.
Sudan Red is an industrial dye linked to potential carcinogenicity.
Medicube disputes the findings using its own third-party lab results, creating an unresolved scientific dispute.
Can the Medicube AGE-R Booster Pro cause Bell’s Palsy?
Some Medicube Booster users claim that the device caused nerve inflammation leading to Bell’s Palsy, and the manufacturer insists otherwise.
Medicube states clinical trials show the device cannot produce sufficient intensity to damage the facial nerve.
The scientific question remains open and is exactly the kind of factual dispute that courts, not brands, are designed to resolve.
Who qualifies to file a Medicube lawsuit claim?
Anyone who purchased a flagged Medicube product and suffered a documented harm may qualify.
This includes AGE-R Booster Pro users with physical injuries, PDRN Cream users who experienced adverse reactions, and consumers who bought products based on false advertising claims.
Proof of purchase and medical records significantly strengthen any claim.
How much money could I get from a Medicube lawsuit settlement?
Settlement amounts will vary widely depending on the type and severity of harm you experienced.
Minor consumer fraud claims in class settlements typically recover small amounts, while serious physical injuries like Bell’s Palsy can result in individual claims worth tens to hundreds of thousands of dollars.
No official settlement amounts exist yet; documented evidence is the most important factor in determining your recovery.
What You Should Do Right Now
The Medicube lawsuit story is still being written. Multiple legal fronts are active. Regulatory findings are stacking up. Consumer complaints keep growing.
If you used the AGE-R Booster Pro and had any physical reaction, that device may have caused your injury. If you used the PDRN Pink Collagen Capsule Cream, especially after July 2026, stop using it immediately and document any skin reaction.
If you bought Medicube products based on claims about pore regeneration, skin repair, or pharmaceutical-level results, those claims may now be proven false by the brand’s own government. That matters legally.
File your complaints officially. Save your receipts. Photograph your injuries. Your documentation is your power.
